Rocket Pharmaceuticals, Inc. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Rocket Pharmaceuticals, Inc. (RCKT) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $445.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2018-03-07
- Rocket Pharmaceuticals, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2015-12-31 was $0.00.
- Rocket Pharmaceuticals, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2015 was $445.00K.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 1 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $445.00K 10-K · filed 2018-03-07 | ||
| 2015-09-30 | $445.00K 10-Q · filed 2016-11-09 | |||
| 2015-05-31 | $445.00K 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |